Fundraising FoxAfferent Pharmaceuticals
San Mateo, US · Delaware corporation · 1 employees on LinkedIn · 5 known investors
Find your way into Afferent Pharmaceuticals
Sign up to see every warm intro you have to Afferent Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Afferent Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
KS
AP
Arthur PappasBoard director
LR
Liam RatcliffeBoard director
JT
PH
Peter HirthBoard director
Investors · 5
Domain AssociatesreportedPrinceton · $200K – $15Mvia Jesse Treu · board
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · Not right? Tell us
Fidelity InvestmentsreportedBoston
How we know: funding news · Not right? Tell us
Jennison AssociatesreportedLondon
How we know: funding news · Not right? Tell us
Third Rock VenturesreportedBoston · $100K – $5Mvia Kevin Starr · board
How we know: board seat on SEC Form D · funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$55M disclosed across 1 round · 2015
▶$55MraisedJul 2015 · 17 investors · PharmaceuticalsRule 506(b)
▶$55MraisedJul 2015 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kevin StarrDirector
- Michael KittExecutive Officer
- Arthur PappasDirector
- Anthony FordExecutive Officer
- Kathleen Sereda GlaubExecutive Officer, Director
- Peter HirthDirector
- Liam RatcliffeDirector
- Jesse TreuDirector
- Offering amount
- $55M
- Amount sold
- $55M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Afferent Pharmaceuticals?
- Afferent Pharmaceuticals was founded by Anthony Ford.
- Who are Afferent Pharmaceuticals's investors?
- Afferent Pharmaceuticals's investors include Pappas Capital, Domain Associates, Fidelity Investments, Jennison Associates, Third Rock Ventures.
- How much funding has Afferent Pharmaceuticals raised?
- Afferent Pharmaceuticals has disclosed $55M raised across 1 round.
- Where is Afferent Pharmaceuticals headquartered?
- Afferent Pharmaceuticals is headquartered in San Mateo, US.